MGC Diagnostics Corporation
MGCD
MGCD was delisted on the 28th of December, 2017.
21 hedge funds and large institutions have $11.2M invested in MGC Diagnostics Corporation in 2014 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 9 increasing their positions, 4 reducing their positions, and 4 closing their positions.
125% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 4
0.97% less ownership
Funds ownership: 24.52% → 23.54% (-0.97%)
9% less funds holding
Funds holding: 23 → 21 (-2)
14% less capital invested
Capital invested by funds: $13.1M → $11.2M (-$1.86M)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Cadence Capital Management
Boston,
Massachusetts
|
+$714K |
| 2 |
PA
Perceptive Advisors
New York
|
+$309K |
| 3 |
Renaissance Technologies
New York
|
+$144K |
| 4 |
NFA
Nationwide Fund Advisors
Columbus,
Ohio
|
+$138K |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$116K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PM
Penbrook Management
New York
|
-$741K |
| 2 |
OAM
Oberweis Asset Management
Lisle,
Illinois
|
-$623K |
| 3 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
-$519K |
| 4 |
AG
Algert Global
San Francisco,
California
|
-$145K |
| 5 |
Morgan Stanley
New York
|
-$132K |
MGCD Hedge Fund Activity: Q1 2014 in Review
21 of the 3,475 institutional investors tracked by Wall St. Rank reported a position in MGC Diagnostics Corporation (MGCD) for Q1 2014, worth a combined $11.2M — down 14% from $13.1M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of MGCD and 2 opened new positions — a net loss of 2 holders — while 4 trimmed existing stakes and 9 added.
The largest buyer was Cadence Capital Management, adding an estimated $714K. The largest seller was Penbrook Management, exiting entirely with an estimated $741K sold.
- 21 institutional investors held MGC Diagnostics Corporation (MGCD) as of Q1 2014, down from 23 in Q4 2013.
- Funds reported $11.2M of MGC Diagnostics Corporation stock for Q1 2014, down 14% quarter-over-quarter.
- 2 funds opened new MGC Diagnostics Corporation positions in Q1 2014 and 4 closed out, a net change of -2 holders.
- The largest MGC Diagnostics Corporation buyer in Q1 2014 was Cadence Capital Management, an estimated $714K added.
- The largest MGC Diagnostics Corporation seller in Q1 2014 was Penbrook Management, an estimated $741K sold.
Based on aggregated 13F filings for Q1 2014.